CCL2 and breast carcinoma: We therefore used Gene Expression-Based Outcome for Breast Cancer Online dataset to analyze and compare the CCL2 expression level among various breast cancer molecular subtypes according to HU or PAM50 subtyping, namely, basal, HER2 positive, luminal A, luminal B, normal-like, and unclassified breast cancer2.